High throughput manufacture of polyurethane foam layers

US12428535B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12428535-B2
Application numberUS-202017621312-A
CountryUS
Kind codeB2
Filing dateJun 22, 2020
Priority dateJun 24, 2019
Publication dateSep 30, 2025
Grant dateSep 30, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described is an at least partly continuous process for making polyurethane foam layers that are suitable for medical applications, in particular in wound dressings, at a high throughput rate. The described process includes a step of accelerated curing of the polyurethane foam performed at a stage of the overall curing process at which the risk of a run-away reaction is minimized.

First claim

Opening claim text (preview).

The invention claimed is: 1. Process for making polyurethane foam layer, said process comprising at least the following steps: (i) at least one mixing step in which one or more polyurethane prepolymer(s) comprising an isocyanate-capped polyol or an isocyanate-capped polyurethane is/are mixed or brought in contact, with each other, and with water, in a mixing or contact zone, wherein said polyurethane prepolymer derive(s) from a reaction between a polyol, and a diisocyanate compound selected from the group consisting of hexamethylene diisocyanate (HDI), toluene diisocyanate (TDI), methylene diphenyl diisocyanate (MDI), and isophorone diisocyanate (IPDI), or any mixture thereof; (ii) at least one layer forming step in which the mixture from step (i) is applied onto a moving substrate to form a layer and to begin the curing process on the substrate; (iii) at least one transporting step during which the foam layer on the substrate from step (ii) is a least partly moved along a production line, during which step the polyurethane prepolymer or precursor thereof in the foam layer at least partly cures, and the thickness of the layer increases due to foaming; (iv) at least one step of accelerated curing, which occurs at a predetermined point in time after conclusion of step (ii) and, correspondingly, at a predetermined location along the production line, wherein curing is accelerated by subjecting the foam as moving on the substrate to radiation heating, wherein said “predetermined point” in time in step (iv) is reached 2 to 10 minutes after the beginning of step (iii), or wherein said “predetermined point” in time in step (iv) is reached once a given volume segment of the foam layer has reached a degree of curing of from 50% to 90%. 2. Process according to claim 1 , wherein said process comprises at least further step (v), which is implemented after step (iv): (v) separately from and after conclusion of step (iv): at least one drying step during which the essentially cured wet foam from step (iv) is dried to reach a predetermined lower water content. 3. The process according to claim 1 , wherein said polyol is selected from the group consisting of a polyester polyol, a polyacrylate polyol, a polyurethane polyol, a polycarbonate polyol, a polyether polyol, a polyesterpolyacrylate polyol, a polyurethane polyacrylate polyol, a polyurethane polyester polyol, a polyurethane polyether polyol, a polyurethane polycarbonate polyol, and a polyester polycarbonate polyol, or a mixture thereof. 4. The process according to claim 1 , wherein the initial thickness of the foam layer as applied on the substrate, i.e. at the beginning of step (ii) is from 100 μm to 8 mm. 5. The process according to claim 1 , wherein said “predetermined point” in time in step (iv) is reached (A) when the thickness of the foam has increased by at least 60% vis-à-vis the thickness of the layer as initially applied in step (ii), or (B) when the peak temperature of foam curing has been reached, or (C) when the temperature of the foam layer is in the range from 25° C. to 35° C., after the temperature had been in the range of from 18° C. to 24° C. at the beginning of step (iii). 6. The process according to claim 1 , wherein said “predetermined location” along the production line in step (iv) is 5 m or more from the point in the production line at which the mixture from step (i) is applied onto the substrate. 7. The process according to claim 1 , wherein the maximum temperature reached by way of the accelerated curing of step (iv) is controlled to be in the range of from 30° C. to 95° C. 8. The process according to claim 2 , wherein the maximum temperature or average temperature, is lower in the drying step (v) than in the accelerated curing step (iv). 9. The process according to claim 1 , wherein the foam resulting after step (iv) or after step (v) is an open cell foam. 10. The process according to claim 1 , wherein the accelerated curing of step (iv) is achieved by infrared heating with 2 or more infrared lamps. 11. A medical dressing comprising a foam produced from the process according to claim 1 . 12. The medical dressing according to claim 11 , wherein said medical dressing further comprises at least one further layer. 13. The process according to claim 1 , wherein said “predetermined point” in time in step (iv) is reached 2 to 10 minutes after the beginning of step (iii). 14. The process according to claim 1 , wherein said “predetermined point” in time in step (iv) is reached once a given volume segment of the foam layer has reached a degree of curing of from 50% to 90%.

Assignees

Inventors

Classifications

  • from polyesters · CPC title

  • Medical applications, e.g. biocompatible scaffolds · CPC title

  • Porous materials, e.g. foams or sponges · CPC title

  • Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof {(A61L15/225 takes precedence)} · CPC title

  • flexible · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12428535B2 cover?
Described is an at least partly continuous process for making polyurethane foam layers that are suitable for medical applications, in particular in wound dressings, at a high throughput rate. The described process includes a step of accelerated curing of the polyurethane foam performed at a stage of the overall curing process at which the risk of a run-away reaction is minimized.
Who is the assignee on this patent?
Moelnlycke Health Care Ab
What technology area does this patent fall under?
Primary CPC classification C08J9/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).